Related Experiment Video
Updated: Apr 9, 2026
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice
Andrew P Sage1, Meritxell Nus1, Lauren L Baker1
1From the Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom (A.P.S, M.S, L.L.B., A.J.F., L.M.M., Z.M.); and Institut National de la Sante et de la Recherche Medicale, Paris, France (Z.M.).
Objective:
To determine the role of regulatory B cell-derived interleukin (IL)-10 in atherosclerosis.
Approach And Results:
We created chimeric Ldlr(-/-) mice with a B cell-specific deficiency in IL-10, and confirmed that purified B cells stimulated with lipopolysaccharide failed to produce IL-10 compared with control Ldlr(-/-) chimeras. Mice lacking B-cell IL-10 demonstrated enhanced splenic B-cell numbers but no major differences in B-cell subsets, T cell or monocyte distribution, and unchanged body weights or serum cholesterol levels compared with control mice. After 8 weeks on high-fat diet, there were no differences in aortic root or aortic arch atherosclerosis. In addition to plaque size, plaque composition (macrophages, T cells, smooth muscle cells, and collagen) was similar between groups.
Conclusions:
In contrast to its prominent regulatory role in many immune-mediated diseases and its proposed modulatory role in atherosclerosis, B cell-derived IL-10 does not alter atherosclerosis in mice.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
07:36Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
